C4X Discovery Company
Combining cutting-edge Drug Discovery technologies and expertise to efficiently deliver world-leading medicines.
Funding Status:
IPO
Industry:
Preclinical Development
Estimated Revenue:
$1M to $10M
Technology:
Biotechnology, Life Science, Pharmaceutical
Acquisitions Number:
1
Headquarters:
Manchester, Manchester, United Kingdom
Total Funding:
5000000.0
Last Funding Date:
2016-09-06
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50
Investors Number:
2.0
Founded Date:
2007-01-01